Viking Therapeutics (VKTX) Misses Q1 EPS by 35c
Tweet
Share
E-mailGet Alerts VKTX Hot Sheet
Join SI Premium – FREE
Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($1.37), $0.35 worse than the analyst estimate of ($1.02).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
- Barclays Downgrades Telenor ASA (TEL:NO) (TELNY) to Underweight
- JPMorgan Starts Angel One Ltd (ANGELONE:IN) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
